|
G |
Acaa2 |
acetyl-CoA acyltransferase 2 |
decreases expression |
ISO |
quinone results in decreased expression of ACAA2 mRNA |
CTD |
PMID:32478940 |
|
NCBI chr18:68,345,136...68,373,246
Ensembl chr18:68,345,012...68,373,249
|
|
G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
decreases expression |
ISO |
quinone results in decreased expression of ACADVL mRNA |
CTD |
PMID:32478940 |
|
NCBI chr10:54,732,875...54,738,102
Ensembl chr10:54,732,469...54,738,075
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions affects localization |
ISO |
AHR protein affects the reaction [quinone results in increased expression of CYP1A1 mRNA] quinone affects the localization of AHR protein |
CTD |
PMID:26558468 PMID:27853106 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
increases expression |
ISO |
quinone results in increased expression of AKR1C2 mRNA |
CTD |
PMID:20491607 |
|
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Alb |
albumin |
affects binding multiple interactions |
ISO EXP |
ALB protein binds to quinone; quinone binds to ALB protein Benzene promotes the reaction [quinone binds to ALB protein]; quinone inhibits the reaction [ALB protein binds to Bromcresol Green] Benzene promotes the reaction [ALB protein binds to quinone] |
CTD |
PMID:9826945 PMID:10746935 PMID:11489749 PMID:11888901 PMID:16484134 PMID:17366815 PMID:22154986 PMID:36436547 More...
|
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Alkbh5 |
alkB homolog 5, RNA demethylase |
increases expression |
ISO |
quinone results in increased expression of ALKBH5 mRNA |
CTD |
PMID:36306860 |
|
NCBI chr10:45,344,888...45,366,331
Ensembl chr10:45,343,395...45,366,331
|
|
G |
Bach1 |
BTB domain and CNC homolog 1 |
multiple interactions affects localization |
ISO |
quinone promotes the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of BACH1 protein] quinone affects the localization of BACH1 protein |
CTD |
PMID:28645578 |
|
NCBI chr11:26,939,429...26,974,876
Ensembl chr11:26,939,480...26,972,447
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
quinone results in increased expression of BAX protein |
CTD |
PMID:20499891 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression multiple interactions |
ISO |
quinone results in decreased expression of BCL2 protein [HIF1A protein co-treated with quinone] results in increased expression of BCL2 protein |
CTD |
PMID:20499891 PMID:30448556 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Becn1 |
beclin 1 |
multiple interactions increases expression |
ISO |
Cyclosporine inhibits the reaction [quinone results in increased expression of BECN1 protein] |
CTD |
PMID:29567065 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Bmi1 |
BMI1 proto-oncogene, polycomb ring finger |
increases expression |
ISO |
quinone results in increased expression of BMI1 mRNA |
CTD |
PMID:28986286 |
|
NCBI chr17:81,332,175...81,341,625
Ensembl chr17:81,332,214...81,388,690
|
|
G |
Casp1 |
caspase 1 |
decreases activity |
ISO |
quinone results in decreased activity of CASP1 protein |
CTD |
PMID:9118901 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp3 |
caspase 3 |
decreases activity increases expression multiple interactions increases activity |
ISO |
quinone results in decreased activity of CASP3 protein quinone analog results in increased expression of CASP3 protein modified form Carnitine inhibits the reaction [quinone results in increased activity of CASP3 protein] [quinone results in increased abundance of Reactive Oxygen Species] which results in decreased activity of CASP3 protein; Acetylcysteine inhibits the reaction [quinone analog results in increased expression of CASP3 protein modified form]; pifithrin promotes the reaction [quinone analog results in increased expression of CASP3 protein modified form]; TRP53 inhibits the reaction [quinone analog results in increased expression of CASP3 protein modified form] |
CTD |
PMID:15337166 PMID:17051661 PMID:20499891 PMID:22960397 PMID:32478940 PMID:33961949 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
decreases activity |
ISO |
quinone results in decreased activity of CASP7 protein |
CTD |
PMID:22960397 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
multiple interactions increases activity |
ISO |
Carnitine inhibits the reaction [quinone results in increased activity of CASP8 protein] |
CTD |
PMID:32478940 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases activity increases expression |
ISO |
Carnitine inhibits the reaction [quinone results in increased activity of CASP9 protein]; Cyclosporine inhibits the reaction [quinone results in increased expression of CASP9 protein] |
CTD |
PMID:29567065 PMID:32478940 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions decreases response to substance increases expression |
ISO |
CAT protein inhibits the reaction [quinone results in increased abundance of Reactive Oxygen Species]; CAT protein inhibits the reaction [quinone results in increased phosphorylation of and results in increased activity of MAPK1 protein]; CAT protein inhibits the reaction [quinone results in increased phosphorylation of and results in increased activity of MAPK3 protein] CAT protein results in decreased susceptibility to quinone quinone results in increased expression of CAT protein |
CTD |
PMID:10193577 PMID:15795063 PMID:25437431 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
increases expression |
ISO |
quinone results in increased expression of CCL11 protein |
CTD |
PMID:17572062 |
|
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
increases expression |
ISO |
quinone results in increased expression of CCL2 protein |
CTD |
PMID:17572062 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
increases expression |
ISO |
quinone results in increased expression of CCL3 protein |
CTD |
PMID:17572062 |
|
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
increases expression |
ISO |
quinone results in increased expression of CCL4 protein |
CTD |
PMID:17572062 |
|
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
increases expression |
ISO |
quinone results in increased expression of CCL5 protein |
CTD |
PMID:17572062 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression multiple interactions |
ISO |
quinone results in decreased expression of CCND1 protein MECOM protein affects the reaction [quinone results in decreased expression of CCND1 protein] |
CTD |
PMID:35092719 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cd80 |
Cd80 molecule |
increases expression |
ISO |
quinone results in increased expression of CD80 protein |
CTD |
PMID:31958493 |
|
NCBI chr11:62,254,543...62,293,414
Ensembl chr11:62,254,624...62,292,030
|
|
G |
Cd86 |
CD86 molecule |
increases expression |
ISO |
quinone results in increased expression of CD86 protein |
CTD |
PMID:31958493 |
|
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression multiple interactions |
ISO |
quinone results in increased expression of CDKN1A mRNA quinone analog results in increased expression of CDKN1A protein Acetylcysteine inhibits the reaction [quinone analog results in increased expression of CDKN1A protein]; pifithrin inhibits the reaction [quinone analog results in increased expression of CDKN1A protein]; TRP53 promotes the reaction [quinone analog results in increased expression of CDKN1A protein] |
CTD |
PMID:14976336 PMID:33961949 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
decreases expression multiple interactions |
ISO |
quinone results in decreased expression of CPT1A mRNA; quinone results in decreased expression of CPT1A protein Carnitine inhibits the reaction [quinone results in decreased expression of CPT1A protein] |
CTD |
PMID:32478940 |
|
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
|
|
G |
Cpt2 |
carnitine palmitoyltransferase 2 |
decreases expression |
ISO |
quinone results in decreased expression of CPT2 mRNA |
CTD |
PMID:32478940 |
|
NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095
|
|
G |
Crat |
carnitine O-acetyltransferase |
decreases expression |
ISO |
quinone results in decreased expression of CRAT mRNA |
CTD |
PMID:32478940 |
|
NCBI chr 3:13,675,684...13,689,282
Ensembl chr 3:13,675,684...13,689,255
|
|
G |
Cryaa |
crystallin, alpha A |
multiple interactions |
ISO |
quinone binds to and affects the folding of CRYAA protein |
CTD |
PMID:29196190 |
|
NCBI chr20:9,783,605...9,787,351
Ensembl chr20:9,783,605...9,787,349
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
multiple interactions |
ISO |
quinone promotes the reaction [[CSF1R protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide] |
CTD |
PMID:7884313 |
|
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
|
|
G |
Csf2 |
colony stimulating factor 2 |
multiple interactions |
ISO |
quinone promotes the reaction [[CSF2 protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide] |
CTD |
PMID:7884313 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
increases expression |
ISO |
quinone results in increased expression of CXCL12 mRNA |
CTD |
PMID:22960397 |
|
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression multiple interactions |
ISO |
quinone results in increased expression of CYP1A1 mRNA AHR protein affects the reaction [quinone results in increased expression of CYP1A1 mRNA] |
CTD |
PMID:20491607 PMID:26558468 PMID:27853106 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
affects expression |
EXP |
quinone affects the expression of CYP2B1 protein |
CTD |
PMID:10462055 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
decreases expression |
EXP |
quinone results in decreased expression of CYP2E1 protein |
CTD |
PMID:10462055 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Dhrs7 |
dehydrogenase/reductase 7 |
increases reduction |
ISO |
DHRS7 protein results in increased reduction of quinone |
CTD |
PMID:24246760 |
|
NCBI chr 6:91,332,259...91,347,856
Ensembl chr 6:91,251,323...91,347,892
|
|
G |
Dkk1 |
dickkopf WNT signaling pathway inhibitor 1 |
increases expression |
ISO |
quinone results in increased expression of DKK1 mRNA |
CTD |
PMID:22960397 |
|
NCBI chr 1:228,381,521...228,385,202
Ensembl chr 1:228,381,521...228,385,202
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions |
ISO |
quinone promotes the reaction [1,4-naphthoquinone results in increased phosphorylation of EGFR protein] |
CTD |
PMID:33814511 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Fto |
FTO, alpha-ketoglutarate dependent dioxygenase |
decreases expression |
ISO |
quinone results in decreased expression of FTO mRNA |
CTD |
PMID:36306860 |
|
NCBI chr19:15,284,898...15,692,142
Ensembl chr19:15,349,696...15,692,083
|
|
G |
Gata3 |
GATA binding protein 3 |
increases expression |
ISO |
quinone results in increased expression of GATA3 mRNA |
CTD |
PMID:28986286 |
|
NCBI chr17:68,643,760...68,666,000
Ensembl chr17:68,643,873...68,665,391
|
|
G |
Gbp1 |
guanylate binding protein 1 |
multiple interactions |
ISO |
quinone promotes the reaction [IFNG protein results in increased expression of GBP1 mRNA] |
CTD |
PMID:31248982 |
|
NCBI chr 2:231,398,136...231,432,773
Ensembl chr 2:231,398,163...231,432,131 Ensembl chr 2:231,398,163...231,432,131
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression |
ISO |
quinone results in increased expression of GCLM protein |
CTD |
PMID:21059386 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gss |
glutathione synthetase |
increases expression multiple interactions |
ISO |
quinone results in increased expression of GSS protein NFE2L2 mRNA affects the reaction [quinone results in increased expression of GSS protein] |
CTD |
PMID:21059386 |
|
NCBI chr 3:144,047,849...144,078,197
Ensembl chr 3:144,047,850...144,078,198
|
|
G |
H2ax |
H2A.X variant histone |
increases phosphorylation multiple interactions increases expression |
ISO |
quinone results in increased phosphorylation of H2AX protein Acetylcysteine inhibits the reaction [quinone analog results in increased expression of H2AX protein modified form]; pifithrin promotes the reaction [quinone analog results in increased expression of H2AX protein modified form]; TRP53 inhibits the reaction [quinone analog results in increased expression of H2AX protein modified form] |
CTD |
PMID:18835433 PMID:31340051 PMID:33961949 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Hadha |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha |
decreases expression multiple interactions |
ISO |
quinone results in decreased expression of HADHA mRNA; quinone results in decreased expression of HADHA protein Carnitine inhibits the reaction [quinone results in decreased expression of HADHA protein] |
CTD |
PMID:32478940 |
|
NCBI chr 6:26,187,969...26,227,605
Ensembl chr 6:26,187,956...26,227,869
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions increases expression |
ISO |
[HIF1A protein co-treated with quinone] results in increased expression of BCL2 protein; [HIF1A protein co-treated with quinone] results in increased expression of LDHA protein; [HIF1A protein co-treated with quinone] results in increased expression of PDK1 protein; [HIF1A protein co-treated with quinone] results in increased expression of PFKFB3 protein; [HIF1A protein co-treated with quinone] results in increased expression of PFKL protein; [HIF1A protein co-treated with quinone] results in increased expression of PGK1 protein; [HIF1A protein co-treated with quinone] results in increased expression of PKM protein; [HIF1A protein co-treated with quinone] results in increased expression of SLC2A1 protein quinone results in increased expression of HIF1A protein |
CTD |
PMID:30448556 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression multiple interactions |
ISO |
quinone results in increased expression of HMOX1 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [quinone results in increased expression of HMOX1 protein]; AG 1879 inhibits the reaction [quinone results in increased expression of HMOX1 protein]; Wortmannin inhibits the reaction [quinone results in increased expression of HMOX1 protein] NFE2L2 mRNA affects the reaction [quinone results in increased expression of HMOX1 protein] |
CTD |
PMID:21059386 PMID:23290930 PMID:25437431 PMID:28645578 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hoxb4 |
homeo box B4 |
increases expression |
ISO |
quinone results in increased expression of HOXB4 mRNA |
CTD |
PMID:28986286 |
|
NCBI chr10:81,284,552...81,287,134
Ensembl chr10:81,284,552...81,287,128
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
[IFNG protein co-treated with Lipopolysaccharides co-treated with quinone] results in increased abundance of Nitric Oxide; quinone inhibits the reaction [Amino Acids, Peptides, and Proteins results in increased expression of IFNG protein] quinone promotes the reaction [IFNG protein results in increased expression of APOL1 mRNA]; quinone promotes the reaction [IFNG protein results in increased expression of GBP1 mRNA]; quinone promotes the reaction [IFNG protein results in increased expression of IRF1 mRNA]; quinone promotes the reaction [IFNG protein results in increased phosphorylation of and results in increased activity of STAT1 protein] |
CTD |
PMID:3137358 PMID:7884313 PMID:31248982 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Igf2bp1 |
insulin-like growth factor 2 mRNA binding protein 1 |
decreases expression |
ISO |
quinone results in decreased expression of IGF2BP1 mRNA |
CTD |
PMID:36306860 |
|
NCBI chr10:80,908,300...80,951,097
Ensembl chr10:80,908,076...80,951,129
|
|
G |
Igf2bp3 |
insulin-like growth factor 2 mRNA binding protein 3 |
decreases expression |
ISO |
quinone results in decreased expression of IGF2BP3 mRNA |
CTD |
PMID:36306860 |
|
NCBI chr 4:78,060,494...78,195,007
Ensembl chr 4:78,060,494...78,194,865
|
|
G |
Il10 |
interleukin 10 |
multiple interactions increases secretion |
ISO |
quinone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL10 protein] quinone results in increased secretion of IL10 protein |
CTD |
PMID:17572062 PMID:31958493 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il12b |
interleukin 12B |
increases secretion |
ISO |
quinone results in increased secretion of IL12B protein |
CTD |
PMID:31958493 |
|
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Il6 |
interleukin 6 |
increases expression |
ISO |
quinone results in increased expression of IL6 protein |
CTD |
PMID:17572062 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Irf1 |
interferon regulatory factor 1 |
multiple interactions |
ISO |
quinone promotes the reaction [IFNG protein results in increased expression of IRF1 mRNA] |
CTD |
PMID:31248982 |
|
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
|
|
G |
Jag1 |
jagged canonical Notch ligand 1 |
decreases expression |
ISO |
quinone results in decreased expression of JAG1 mRNA |
CTD |
PMID:22960397 |
|
NCBI chr 3:124,406,783...124,442,220
Ensembl chr 3:124,406,794...124,442,209
|
|
G |
Kdr |
kinase insert domain receptor |
multiple interactions |
ISO |
quinone analog binds to and results in decreased activity of KDR protein |
CTD |
PMID:16302797 |
|
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Kitlg |
KIT ligand |
increases expression |
ISO |
quinone results in increased expression of KITLG mRNA |
CTD |
PMID:22960397 |
|
NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
|
|
G |
Ldha |
lactate dehydrogenase A |
multiple interactions increases expression |
ISO |
[HIF1A protein co-treated with quinone] results in increased expression of LDHA protein quinone results in increased expression of LDHA protein |
CTD |
PMID:30448556 |
|
NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
|
|
G |
Maff |
MAF bZIP transcription factor F |
increases expression |
ISO |
quinone results in increased expression of MAFF mRNA |
CTD |
PMID:20491607 |
|
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [quinone results in increased phosphorylation of and results in increased activity of MAPK1 protein]; CAT protein inhibits the reaction [quinone results in increased phosphorylation of and results in increased activity of MAPK1 protein]; quinone results in increased phosphorylation of and results in increased activity of MAPK1 protein |
CTD |
PMID:15795063 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [quinone results in increased phosphorylation of and results in increased activity of MAPK3 protein]; CAT protein inhibits the reaction [quinone results in increased phosphorylation of and results in increased activity of MAPK3 protein]; quinone results in increased phosphorylation of and results in increased activity of MAPK3 protein |
CTD |
PMID:15795063 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapt |
microtubule-associated protein tau |
multiple interactions |
ISO |
quinone promotes the reaction [MAPT protein binds to MAPT protein] |
CTD |
PMID:16180106 |
|
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
|
|
G |
Mecom |
MDS1 and EVI1 complex locus |
multiple interactions decreases expression |
ISO |
MECOM protein affects the reaction [quinone results in decreased expression of CCND1 protein]; MECOM protein affects the reaction [quinone results in decreased phosphorylation of MTOR protein] quinone results in decreased expression of MECOM protein |
CTD |
PMID:35092719 |
|
NCBI chr 2:112,909,353...113,464,583
Ensembl chr 2:112,909,321...113,464,590
|
|
G |
Mettl3 |
methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit |
decreases expression |
ISO |
quinone results in decreased expression of METTL3 mRNA |
CTD |
PMID:36306860 |
|
NCBI chr15:25,002,505...25,014,097
Ensembl chr15:25,003,172...25,014,041
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
ISO |
[[[MPO protein co-treated with Hydrogen Peroxide] results in increased metabolism of hydroquinone] which results in increased chemical synthesis of quinone] which results in decreased activity of PTPN2 protein; [[MPO protein co-treated with Hydrogen Peroxide] results in increased metabolism of hydroquinone] which results in increased chemical synthesis of quinone |
CTD |
PMID:31248982 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mt1 |
metallothionein 1 |
increases expression |
ISO |
quinone results in increased expression of MT1 mRNA |
CTD |
PMID:14998373 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
multiple interactions decreases phosphorylation |
ISO |
MECOM protein affects the reaction [quinone results in decreased phosphorylation of MTOR protein] |
CTD |
PMID:35092719 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Myb |
MYB proto-oncogene, transcription factor |
increases activity multiple interactions |
ISO |
quinone results in increased activity of MYB protein MYB protein promotes the reaction [quinone results in increased expression of TOP2A mRNA] |
CTD |
PMID:18778717 |
|
NCBI chr 1:15,939,771...15,973,367
Ensembl chr 1:15,939,761...15,973,057
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions increases expression |
ISO |
NFE2L2 mRNA affects the reaction [quinone results in increased expression of GSS protein]; NFE2L2 mRNA affects the reaction [quinone results in increased expression of HMOX1 protein]; quinone affects the localization of and results in increased degradation of NFE2L2 protein; quinone inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of NFE2L2 protein]; quinone results in increased expression of and affects the localization of NFE2L2 protein quinone results in increased expression of NFE2L2 mRNA quinone results in increased expression of and affects the localization of and results in increased activity of NFE2L2 protein |
CTD |
PMID:21059386 PMID:25437431 PMID:26862668 PMID:28645578 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nox1 |
NADPH oxidase 1 |
multiple interactions increases expression |
ISO |
[quinone results in increased expression of NOX1 protein] which results in increased abundance of Reactive Oxygen Species |
CTD |
PMID:25437431 |
|
NCBI chr X:97,279,058...97,332,291
Ensembl chr X:97,279,056...97,302,236
|
|
G |
Nox4 |
NADPH oxidase 4 |
decreases expression |
ISO |
quinone results in decreased expression of NOX4 protein |
CTD |
PMID:30448556 |
|
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression |
ISO |
quinone results in increased expression of NQO1 protein quinone results in increased expression of NQO1 mRNA; quinone results in increased expression of NQO1 protein |
CTD |
PMID:8652659 PMID:20491607 PMID:21059386 PMID:25437431 PMID:28645578 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
decreases expression |
ISO |
quinone results in decreased expression of OGG1 mRNA |
CTD |
PMID:26456483 |
|
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
|
|
G |
Pdk1 |
pyruvate dehydrogenase kinase 1 |
multiple interactions |
ISO |
[HIF1A protein co-treated with quinone] results in increased expression of PDK1 protein |
CTD |
PMID:30448556 |
|
NCBI chr 3:56,705,824...56,733,040
Ensembl chr 3:56,705,871...56,733,038
|
|
G |
Pfkfb3 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
increases expression multiple interactions |
ISO |
quinone results in increased expression of PFKFB3 protein [HIF1A protein co-treated with quinone] results in increased expression of PFKFB3 protein |
CTD |
PMID:30448556 |
|
NCBI chr17:66,983,629...67,064,702
Ensembl chr17:66,983,686...67,063,125
|
|
G |
Pfkl |
phosphofructokinase, liver type |
increases expression multiple interactions |
ISO |
quinone results in increased expression of PFKL protein [HIF1A protein co-treated with quinone] results in increased expression of PFKL protein |
CTD |
PMID:30448556 |
|
NCBI chr20:10,664,285...10,686,324
Ensembl chr20:10,664,272...10,686,315
|
|
G |
Pgk1 |
phosphoglycerate kinase 1 |
increases expression multiple interactions |
ISO |
quinone results in increased expression of PGK1 protein [HIF1A protein co-treated with quinone] results in increased expression of PGK1 protein |
CTD |
PMID:30448556 |
|
NCBI chr X:71,271,454...71,287,429
Ensembl chr X:71,271,440...71,287,418
|
|
G |
Pink1 |
PTEN induced kinase 1 |
multiple interactions increases expression |
ISO |
Acetylcysteine inhibits the reaction [quinone results in increased expression of PINK1 protein]; Cyclosporine inhibits the reaction [quinone results in increased expression of PINK1 mRNA]; Cyclosporine inhibits the reaction [quinone results in increased expression of PINK1 protein] quinone results in increased expression of PINK1 mRNA; quinone results in increased expression of PINK1 protein |
CTD |
PMID:29567065 |
|
NCBI chr 5:150,530,523...150,542,635
Ensembl chr 5:150,530,523...150,542,635
|
|
G |
Pkm |
pyruvate kinase M1/2 |
multiple interactions increases expression |
ISO |
Acetylcysteine inhibits the reaction [quinone results in increased degradation of PKM protein]; quinone results in increased degradation of and results in decreased expression of PKM protein; Reactive Oxygen Species affects the reaction [quinone results in increased degradation of PKM protein] quinone results in increased expression of PKM protein [HIF1A protein co-treated with quinone] results in increased expression of PKM protein |
CTD |
PMID:25437431 PMID:30448556 |
|
NCBI chr 8:60,057,629...60,079,600
Ensembl chr 8:60,057,402...60,079,599
|
|
G |
Prkcb |
protein kinase C, beta |
increases expression |
ISO |
quinone results in increased expression of PRKCB protein |
CTD |
PMID:31958493 |
|
NCBI chr 1:176,832,173...177,163,539
Ensembl chr 1:176,832,226...177,163,536
|
|
G |
Prkn |
parkin RBR E3 ubiquitin protein ligase |
increases expression multiple interactions |
ISO |
quinone results in increased expression of PRKN mRNA; quinone results in increased expression of PRKN protein Acetylcysteine inhibits the reaction [quinone results in increased expression of PRKN protein]; Cyclosporine inhibits the reaction [quinone results in increased expression of PRKN mRNA]; Cyclosporine inhibits the reaction [quinone results in increased expression of PRKN protein] |
CTD |
PMID:29567065 |
|
NCBI chr 1:48,688,651...49,882,520
Ensembl chr 1:48,690,556...49,882,555
|
|
G |
Ptpn1 |
protein tyrosine phosphatase, non-receptor type 1 |
decreases activity |
ISO |
quinone results in decreased activity of PTPN1 protein |
CTD |
PMID:33814511 |
|
NCBI chr 3:156,638,811...156,687,503
Ensembl chr 3:156,638,769...156,687,504
|
|
G |
Ptpn2 |
protein tyrosine phosphatase, non-receptor type 2 |
multiple interactions |
ISO |
[[[MPO protein co-treated with Hydrogen Peroxide] results in increased metabolism of hydroquinone] which results in increased chemical synthesis of quinone] which results in decreased activity of PTPN2 protein; Glutathione inhibits the reaction [quinone results in decreased activity of PTPN2 protein]; quinone binds to and results in decreased activity of PTPN2 protein; Vanadates inhibits the reaction [quinone results in decreased activity of PTPN2 protein] |
CTD |
PMID:31248982 |
|
NCBI chr18:61,229,012...61,294,662
Ensembl chr18:61,229,014...61,294,627
|
|
G |
Runx2 |
RUNX family transcription factor 2 |
increases expression |
ISO |
quinone results in increased expression of RUNX2 mRNA |
CTD |
PMID:22960397 |
|
NCBI chr 9:16,167,504...16,492,826
Ensembl chr 9:16,167,482...16,492,167
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
multiple interactions |
ISO |
[HIF1A protein co-treated with quinone] results in increased expression of SLC2A1 protein |
CTD |
PMID:30448556 |
|
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
|
|
G |
Sod1 |
superoxide dismutase 1 |
increases expression |
ISO |
quinone results in increased expression of SOD1 protein |
CTD |
PMID:25437431 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
increases expression |
ISO |
quinone results in increased expression of SOD2 protein |
CTD |
PMID:25437431 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sqstm1 |
sequestosome 1 |
decreases expression multiple interactions |
ISO |
quinone results in decreased expression of SQSTM1 protein Cyclosporine inhibits the reaction [quinone results in decreased expression of SQSTM1 protein] |
CTD |
PMID:29567065 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
increases phosphorylation |
ISO |
quinone results in increased phosphorylation of SRC protein |
CTD |
PMID:23290930 |
|
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
multiple interactions |
ISO |
quinone promotes the reaction [IFNG protein results in increased phosphorylation of and results in increased activity of STAT1 protein] |
CTD |
PMID:31248982 |
|
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
quinone inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] |
CTD |
PMID:21235518 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Top2a |
DNA topoisomerase II alpha |
affects activity decreases activity increases expression multiple interactions increases activity |
ISO |
quinone affects the activity of TOP2A protein; quinone metabolite affects the activity of TOP2A protein quinone results in decreased activity of TOP2A protein quinone results in increased expression of TOP2A mRNA MYB protein promotes the reaction [quinone results in increased expression of TOP2A mRNA]; quinone binds to and affects the activity of TOP2A protein; quinone binds to and results in decreased activity of TOP2A protein quinone results in increased activity of TOP2A protein |
CTD |
PMID:7586126 PMID:9118903 PMID:9118913 PMID:11468185 PMID:15833037 PMID:15935817 PMID:16906772 PMID:18778717 PMID:20034485 PMID:22218491 PMID:31340051 PMID:33760604 More...
|
|
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
|
|
G |
Top2b |
DNA topoisomerase II beta |
affects activity |
ISO |
quinone affects the activity of TOP2B protein |
CTD |
PMID:33760604 |
|
NCBI chr15:9,051,340...9,111,721
Ensembl chr15:9,051,341...9,112,085
|
|
G |
Tp53 |
tumor protein p53 |
increases expression multiple interactions |
ISO |
quinone results in increased expression of TP53 protein quinone analog results in increased expression of TRP53 protein modified form Acetylcysteine inhibits the reaction [quinone analog results in increased expression of TRP53 protein modified form]; Acetylcysteine inhibits the reaction [quinone analog results in increased expression of TRP53 protein]; quinone analog results in increased expression of and affects the localization of TRP53 protein; TRP53 inhibits the reaction [quinone analog results in increased expression of CASP3 protein modified form]; TRP53 inhibits the reaction [quinone analog results in increased expression of H2AX protein modified form]; TRP53 promotes the reaction [quinone analog results in increased expression of CDKN1A protein] |
CTD |
PMID:20499891 PMID:33961949 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Wnt5a |
Wnt family member 5A |
increases expression |
ISO |
quinone results in increased expression of WNT5A mRNA |
CTD |
PMID:22960397 |
|
NCBI chr16:3,697,032...3,718,230
Ensembl chr16:3,697,032...3,718,234
|
|
G |
Ythdc2 |
YTH N6-methyladenosine RNA binding protein C2 |
decreases expression |
ISO |
quinone results in decreased expression of YTHDC2 mRNA |
CTD |
PMID:36306860 |
|
NCBI chr18:37,266,559...37,331,681
Ensembl chr18:37,265,836...37,331,023
|
|
G |
Ythdf1 |
YTH N6-methyladenosine RNA binding protein F1 |
increases expression |
ISO |
quinone results in increased expression of YTHDF1 mRNA |
CTD |
PMID:36306860 |
|
NCBI chr 3:168,024,660...168,040,172
Ensembl chr 3:168,024,663...168,040,172
|
|
G |
Ythdf2 |
YTH N6-methyladenosine RNA binding protein F2 |
increases expression |
ISO |
quinone results in increased expression of YTHDF2 mRNA |
CTD |
PMID:36306860 |
|
NCBI chr 5:144,381,426...144,407,126
Ensembl chr 5:144,381,431...144,408,144
|
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
increases expression multiple interactions |
ISO |
N-acetyl-4-benzoquinoneimine results in increased expression of ACTA2 mRNA; N-acetyl-4-benzoquinoneimine results in increased expression of ACTA2 protein andrographolide inhibits the reaction [N-acetyl-4-benzoquinoneimine results in increased expression of ACTA2 mRNA]; andrographolide inhibits the reaction [N-acetyl-4-benzoquinoneimine results in increased expression of ACTA2 protein] |
CTD |
PMID:28286204 PMID:29355602 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Adarb2 |
adenosine deaminase RNA specific B2 |
affects response to substance |
ISO |
ADARB2 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr17:61,750,437...62,300,984
Ensembl chr17:61,756,067...62,300,831
|
|
G |
Alcam |
activated leukocyte cell adhesion molecule |
affects response to substance |
ISO |
ALCAM gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr11:48,336,123...48,536,296
Ensembl chr11:48,336,169...48,537,954
|
|
G |
Aldh1a3 |
aldehyde dehydrogenase 1 family, member A3 |
affects response to substance |
ISO |
ALDH1A3 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr 1:119,982,272...120,017,416
Ensembl chr 1:119,982,277...120,017,436
|
|
G |
Bmp2 |
bone morphogenetic protein 2 |
increases expression |
ISO |
N-acetyl-4-benzoquinoneimine results in increased expression of BMP2 mRNA |
CTD |
PMID:28286204 |
|
NCBI chr 3:120,812,660...120,822,579
Ensembl chr 3:120,812,882...120,821,397
|
|
G |
Bpnt2 |
3'(2'), 5'-bisphosphate nucleotidase 2 |
affects response to substance |
ISO |
BPNT2 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr 5:17,775,684...17,802,570
Ensembl chr 5:17,772,608...17,802,570
|
|
G |
C11h3orf38 |
similar to human chromosome 3 open reading frame 38 |
affects response to substance |
ISO |
C3ORF38 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr11:2,483,983...2,488,631
Ensembl chr11:2,481,189...2,488,660
|
|
G |
Cacna1h |
calcium voltage-gated channel subunit alpha1 H |
affects response to substance |
ISO |
CACNA1H gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr10:14,390,104...14,448,204
Ensembl chr10:14,390,113...14,448,376
|
|
G |
Cald1 |
caldesmon 1 |
affects response to substance |
ISO |
CALD1 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr 4:63,265,781...63,446,938
Ensembl chr 4:63,265,942...63,446,932
|
|
G |
Ccdc25 |
coiled-coil domain containing 25 |
affects response to substance |
ISO |
CCDC25 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr15:40,055,368...40,087,758
Ensembl chr15:40,055,368...40,087,758
|
|
G |
Cd9 |
CD9 molecule |
affects response to substance |
ISO |
CD9 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr 4:158,256,328...158,289,136
Ensembl chr 4:158,256,328...158,289,222
|
|
G |
Cep44 |
centrosomal protein 44 |
affects response to substance |
ISO |
CEP44 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr16:33,711,548...33,733,226
Ensembl chr16:33,711,559...33,733,225
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
affects response to substance |
ISO |
CNR1 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
increases expression multiple interactions |
ISO |
N-acetyl-4-benzoquinoneimine results in increased expression of COL1A1 mRNA andrographolide inhibits the reaction [N-acetyl-4-benzoquinoneimine results in increased expression of COL1A1 mRNA] |
CTD |
PMID:28286204 PMID:29355602 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
increases expression |
ISO |
N-acetyl-4-benzoquinoneimine results in increased expression of COL1A2 mRNA |
CTD |
PMID:28286204 |
|
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
increases expression multiple interactions |
ISO |
N-acetyl-4-benzoquinoneimine results in increased expression of COL3A1 mRNA andrographolide inhibits the reaction [N-acetyl-4-benzoquinoneimine results in increased expression of COL3A1 mRNA] |
CTD |
PMID:28286204 PMID:29355602 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Cpa6 |
carboxypeptidase A6 |
affects response to substance |
ISO |
CPA6 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr 5:8,526,708...8,888,492
Ensembl chr 5:8,526,741...8,888,485
|
|
G |
Cst5 |
cystatin D |
affects response to substance |
ISO |
CST5 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr 3:137,573,194...137,577,754
Ensembl chr 3:137,573,194...137,577,754
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions increases abundance |
ISO |
CYP1A2 protein results in increased chemical synthesis of and results in increased abundance of N-acetyl-4-benzoquinoneimine CYP1A2 protein results in increased abundance of N-acetyl-4-benzoquinoneimine |
CTD |
PMID:19679878 PMID:24661219 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
increases abundance |
ISO |
CYP2D6 protein results in increased abundance of N-acetyl-4-benzoquinoneimine |
CTD |
PMID:24661219 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions increases chemical synthesis increases abundance |
ISO EXP |
CYP2E1 protein results in increased chemical synthesis of and results in increased abundance of N-acetyl-4-benzoquinoneimine CYP2E1 results in increased chemical synthesis of N-acetyl-4-benzoquinoneimine CYP2E1 protein results in increased abundance of N-acetyl-4-benzoquinoneimine |
CTD |
PMID:19679878 PMID:20566340 PMID:24661219 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases abundance |
ISO |
CYP3A4 protein results in increased abundance of N-acetyl-4-benzoquinoneimine |
CTD |
PMID:24661219 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Dmrt1 |
doublesex and mab-3 related transcription factor 1 |
affects response to substance |
ISO |
DMRT1 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr 1:223,142,859...223,241,333
Ensembl chr 1:223,142,859...223,241,333
|
|
G |
Dnttip1 |
deoxynucleotidyltransferase, terminal, interacting protein 1 |
affects response to substance |
ISO |
DNTTIP1 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr 3:153,481,718...153,505,403
Ensembl chr 3:153,481,705...153,505,759
|
|
G |
Dsc3 |
desmocollin 3 |
affects response to substance |
ISO |
DSC3 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr18:11,379,759...11,413,797
Ensembl chr18:11,377,347...11,413,797
|
|
G |
Etnk2 |
ethanolamine kinase 2 |
affects response to substance |
ISO |
ETNK2 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr13:44,811,012...44,829,052
Ensembl chr13:44,811,015...44,829,037
|
|
G |
Fbxo39 |
F-box protein 39 |
affects response to substance |
ISO |
FBXO39 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr10:56,929,699...56,934,911
Ensembl chr10:56,932,297...56,934,906
|
|
G |
Frk |
fyn-related Src family tyrosine kinase |
affects response to substance |
ISO |
FRK gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr20:38,265,416...38,371,038
Ensembl chr20:38,265,280...38,371,114
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
multiple interactions affects response to substance |
ISO |
[GPX1 protein co-treated with SOD1 protein] affects the susceptibility to N-acetyl-4-benzoquinoneimine GPX1 protein affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:16636302 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
affects metabolic processing increases metabolic processing increases glutathionylation multiple interactions |
ISO EXP |
GSTP1 protein polymorphism affects the metabolism of N-acetyl-4-benzoquinoneimine metabolite GSTP1 protein results in increased metabolism of N-acetyl-4-benzoquinoneimine GSTP1 protein results in increased glutathionylation of N-acetyl-4-benzoquinoneimine NQO1 protein inhibits the reaction [GSTP1 protein results in increased glutathionylation of N-acetyl-4-benzoquinoneimine] |
CTD |
PMID:24185126 PMID:24552538 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Hdac4 |
histone deacetylase 4 |
affects response to substance |
ISO |
HDAC4 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr 9:92,503,467...92,750,164
Ensembl chr 9:92,507,611...92,750,164
|
|
G |
Hid1 |
HID1 domain containing |
affects response to substance |
ISO |
HID1 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr10:100,589,555...100,610,050
Ensembl chr10:100,589,555...100,610,041
|
|
G |
Il23r |
interleukin 23 receptor |
affects response to substance |
ISO |
IL23R gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr 4:96,580,568...96,672,540
Ensembl chr 4:96,580,714...96,674,021
|
|
G |
Kcnj3 |
potassium inwardly-rectifying channel, subfamily J, member 3 |
affects response to substance |
ISO |
KCNJ3 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr 3:39,944,896...40,106,646
Ensembl chr 3:39,945,351...40,109,124
|
|
G |
Kcnu1 |
potassium calcium-activated channel subfamily U member 1 |
affects response to substance |
ISO |
KCNU1 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr16:66,141,696...66,229,493
Ensembl chr16:66,141,976...66,229,465
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
multiple interactions affects metabolic processing |
ISO |
KEAP1 protein inhibits the reaction [NQO1 protein results in increased metabolism of N-acetyl-4-benzoquinoneimine] N-acetyl-4-benzoquinoneimine affects the metabolism of KEAP1 protein |
CTD |
PMID:18785192 PMID:19246624 |
|
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Lama4 |
laminin subunit alpha 4 |
affects response to substance |
ISO |
LAMA4 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr20:42,392,268...42,533,347
Ensembl chr20:42,392,268...42,533,347
|
|
G |
Lmx1a |
LIM homeobox transcription factor 1 alpha |
affects response to substance |
ISO |
LMX1A gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr13:79,834,614...79,978,253
Ensembl chr13:79,835,019...79,978,253
|
|
G |
Magi2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
affects response to substance |
ISO |
MAGI2 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr 4:14,386,389...15,870,036
Ensembl chr 4:14,386,399...15,870,240
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases phosphorylation |
ISO |
N-acetyl-4-benzoquinoneimine results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:28286204 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases phosphorylation |
ISO |
N-acetyl-4-benzoquinoneimine results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:28286204 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mctp1 |
multiple C2 and transmembrane domain containing 1 |
affects response to substance |
ISO |
MCTP1 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr 2:6,071,408...6,761,833
Ensembl chr 2:6,065,808...6,761,833
|
|
G |
Mfsd4a |
major facilitator superfamily domain containing 4A |
affects response to substance |
ISO |
MFSD4A gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr13:43,469,488...43,510,467
Ensembl chr13:43,469,488...43,510,467
|
|
G |
Mir135a |
microRNA 135a |
affects response to substance |
ISO |
MIR135A2 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr 7:26,611,990...26,612,089
Ensembl chr 7:26,611,990...26,612,089
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
increases expression |
ISO |
N-acetyl-4-benzoquinoneimine results in increased expression of MMP2 mRNA |
CTD |
PMID:28286204 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mtus2 |
microtubule associated scaffold protein 2 |
affects response to substance |
ISO |
MTUS2 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr12:6,706,531...7,078,331
Ensembl chr12:6,706,532...7,078,331
|
|
G |
Neb |
nebulin |
affects response to substance |
ISO |
NEB gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr 3:36,613,677...36,811,618
Ensembl chr 3:36,613,716...36,811,574
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
affects localization increases activity multiple interactions |
ISO |
N-acetyl-4-benzoquinoneimine affects the localization of NFE2L2 protein N-acetyl-4-benzoquinoneimine results in increased activity of NFE2L2 protein NFE2L2 protein affects the reaction [N-acetyl-4-benzoquinoneimine results in increased expression of NQO1 mRNA]; NFE2L2 protein promotes the reaction [NQO1 protein results in increased metabolism of N-acetyl-4-benzoquinoneimine] |
CTD |
PMID:18785192 PMID:19246624 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nhlrc3 |
NHL repeat containing 3 |
affects response to substance |
ISO |
NHLRC3 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr 2:137,527,843...137,542,258
Ensembl chr 2:137,530,012...137,534,879 Ensembl chr 2:137,530,012...137,534,879
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions increases expression increases metabolic processing increases reduction |
ISO |
KEAP1 protein inhibits the reaction [NQO1 protein results in increased metabolism of N-acetyl-4-benzoquinoneimine]; NFE2L2 protein affects the reaction [N-acetyl-4-benzoquinoneimine results in increased expression of NQO1 mRNA]; NFE2L2 protein promotes the reaction [NQO1 protein results in increased metabolism of N-acetyl-4-benzoquinoneimine] NQO1 protein results in increased reduction of N-acetyl-4-benzoquinoneimine NQO1 protein inhibits the reaction [GSTP1 protein results in increased glutathionylation of N-acetyl-4-benzoquinoneimine] |
CTD |
PMID:17188792 PMID:18785192 PMID:19246624 PMID:24552538 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nqo2 |
N-ribosyldihydronicotinamide:quinone dehydrogenase 2 |
multiple interactions |
ISO |
NQO2 protein results in increased reduction of and results in decreased glutathionylation of N-acetyl-4-benzoquinoneimine; Tacrine inhibits the reaction [NQO2 protein results in increased reduction of N-acetyl-4-benzoquinoneimine] |
CTD |
PMID:29281794 |
|
NCBI chr17:30,909,482...30,938,725
Ensembl chr17:30,909,187...30,938,320
|
|
G |
Pcbd2 |
pterin-4 alpha-carbinolamine dehydratase 2 |
affects response to substance |
ISO |
PCBD2 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr17:8,845,161...8,896,343
Ensembl chr17:8,845,084...8,910,539
|
|
G |
Pvt1 |
Pvt1 oncogene |
affects response to substance |
ISO |
PVT1 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr 7:93,656,528...93,879,938
|
|
G |
Rab3il1 |
RAB3A interacting protein-like 1 |
affects response to substance |
ISO |
RAB3IL1 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr 1:206,646,168...206,682,718
Ensembl chr 1:206,646,155...206,679,972
|
|
G |
Rap1gap2 |
RAP1 GTPase activating protein 2 |
affects response to substance |
ISO |
RAP1GAP2 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr10:59,255,400...59,472,536
Ensembl chr10:59,255,278...59,472,170
|
|
G |
Slc39a11 |
solute carrier family 39, member 11 |
affects response to substance |
ISO |
SLC39A11 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr10:98,275,958...98,697,042
Ensembl chr10:98,275,960...98,611,295
|
|
G |
Slit2 |
slit guidance ligand 2 |
affects response to substance |
ISO |
SLIT2 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr14:62,616,337...62,955,934
Ensembl chr14:62,617,067...62,955,948
|
|
G |
Snx16 |
sorting nexin 16 |
affects response to substance |
ISO |
SNX16 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr 2:91,335,896...91,357,622
Ensembl chr 2:91,336,092...91,357,619
|
|
G |
Sod1 |
superoxide dismutase 1 |
multiple interactions |
ISO |
[GPX1 protein co-treated with SOD1 protein] affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:16636302 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Spag16 |
sperm associated antigen 16 |
affects response to substance |
ISO |
SPAG16 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr 9:71,333,005...72,252,772
Ensembl chr 9:71,332,992...72,252,708
|
|
G |
Stab1 |
stabilin 1 |
affects response to substance |
ISO |
STAB1 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr16:6,330,435...6,360,934
Ensembl chr16:6,330,444...6,360,923
|
|
G |
Syne3 |
spectrin repeat containing, nuclear envelope family member 3 |
affects response to substance |
ISO |
SYNE3 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr 6:123,872,895...123,964,773
Ensembl chr 6:123,873,174...123,953,409
|
|
G |
Tac1 |
tachykinin, precursor 1 |
increases secretion |
EXP |
N-acetyl-4-benzoquinoneimine results in increased secretion of TAC1 protein |
CTD |
PMID:20720158 |
|
NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:35,679,704...35,687,178
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
increases expression |
ISO |
N-acetyl-4-benzoquinoneimine results in increased expression of TGFB1 mRNA |
CTD |
PMID:28286204 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
increases expression |
ISO |
N-acetyl-4-benzoquinoneimine results in increased expression of TIMP1 mRNA |
CTD |
PMID:28286204 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Top2a |
DNA topoisomerase II alpha |
decreases activity |
ISO |
N-acetyl-4-benzoquinoneimine results in decreased activity of TOP2A protein |
CTD |
PMID:15035644 |
|
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
|
|
G |
Tpd52l1 |
TPD52 like 1 |
affects response to substance |
ISO |
TPD52L1 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr 1:26,172,038...26,290,704
Ensembl chr 1:26,172,170...26,291,109
|
|
G |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
increases activity multiple interactions affects response to substance |
ISO EXP |
N-acetyl-4-benzoquinoneimine results in increased activity of TRPA1 protein 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [N-acetyl-4-benzoquinoneimine results in increased activity of TRPA1 protein] TRPA1 affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:20720158 |
|
NCBI chr 5:4,379,862...4,434,133
Ensembl chr 5:4,379,999...4,433,570
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
decreases activity multiple interactions |
EXP |
N-acetyl-4-benzoquinoneimine results in decreased activity of TXNRD1 protein Glutathione inhibits the reaction [N-acetyl-4-benzoquinoneimine results in decreased activity of TXNRD1 protein] |
CTD |
PMID:24661219 |
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
G |
Ubash3a |
ubiquitin associated and SH3 domain containing, A |
affects response to substance |
ISO |
UBASH3A gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr20:9,291,471...9,334,685
Ensembl chr20:9,292,139...9,329,224
|
|
G |
Ube2e2 |
ubiquitin-conjugating enzyme E2E 2 |
affects response to substance |
ISO |
UBE2E2 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr15:6,980,241...7,257,912
Ensembl chr15:6,980,474...7,257,532
|
|
G |
Vwc2 |
von Willebrand factor C domain containing 2 |
affects response to substance |
ISO |
VWC2 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr14:85,683,670...85,825,068
Ensembl chr14:85,684,414...85,818,524
|
|
G |
Wfdc3 |
WAP four-disulfide core domain 3 |
affects response to substance |
ISO |
WFDC3 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine |
CTD |
PMID:21177773 |
|
NCBI chr 3:153,464,862...153,478,952
Ensembl chr 3:153,464,862...153,478,952
|
|